Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
The Department of Chemistry, Section for Chemical Biology invites applicants for a PhD fellowship in chemical methods for half-life extension of therapeutic peptides. The project is part of
-
research activities conducted by the Exfimo group. Who are we looking for? We are looking for a highly motivated candidate with a background in immunology, infection biology or molecular biology. Applicants
-
The Biological Chemistry section at the Department of Chemistry invites applicants for an externally funded, three-year PhD fellowship within structural enzymology and time-resolved crystallography
-
for position”. We must have your application at the latest on 18-10-2026 at 23:59 (Danish time). Applications or other material received after the deadline will not be considered. Where to apply Website https
-
PhD Scholarship in Development of Cement-Free Living Building Materials for Sustainable Construction
. Working closely with collaborators across microbiology, materials science, bioengineering, and additive manufacturing. We are looking for a candidate who is curious about fungal and bacterial biology
-
We are offering a 6-month Research Assistant position and 3-year PhD fellowship in Structural biology and Protein/Vaccine design commencing 15 September 2026. Background The Novo Nordisk Foundation
-
, especially but not exclusively related to AI, https://digitalcurriculum.au.dk in collaboration with colleagues from CED and NAT Join as a co-teacher in a few of the departments’ workshops and teaching
-
Over the last decade, research has highlighted the critical role that host-associated microbiomes play in the different biological processes of the host. There has been increasing interest in studying
-
, mathematics, biology, and epidemiology, developing and applying novel statistical methods and deep learning approaches for global health challenges. The group’s research spans disease modelling, genomic
-
on epigenetic therapies. This is done by bridging between clinical research at Rigshospitalet and the basic cancer biology research at BRIC, and in international collaborations with, among others